Aug 14 (Reuters) - More than one in four U.S. adults with diabetes used one of the injectable medicines that target the GLP-1 ...

One popular health platforms is promoting GLP-1 microdosing for weight loss: But how safe and effective is this approach?

In this retrospective study, patients who started a GLP-1 agonist experienced significant declines in hidradenitis ...

No blanket recommendation can be made for SGLT2 inhibitors and GLP-1 receptor agonists in adults with type 2 diabetes (T2D) ...

The rapid adoption of GLP-1 receptor agonists has fundamentally altered obesity management, with these medications now ...

The FDA said it's taking action to protect patients from unapproved animal-derived thyroid medications and expressed concern ...

An observational study of 160,000 patients with diabetes taking GLP-1 drugs finds no heightened risk for retinopathy ...

Eli Lilly’s GLP-1 pill helped some participants lose up to 15% body weight. But is it as effective as the injection? Here's ...

A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...

SGLT-2 inhibitor and GLP-1 receptor agonist drugs should be used in all or almost all adults with type 2 diabetes at higher ...

A Cell Metabolism study reveals that GIPR signaling in oligodendrocytes enhances brain access and weight-loss efficacy of GLP ...

The agency shared information from reports by users of compounded semaglutide and tirzepatide who have experienced health ...